Menu
Recruiting NCT05120635

Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans

No phase Interventional Fear GAD Emotional Memory PTSD

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Deep Brain Stimulation, Virtual and augmented reality tasks.
Who it may be relevant to
Registry conditions: Fear, GAD, Emotional Memory, PTSD. Basic parameters: 18 years — 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Anxiety disorders such as post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD) affect a large number of individuals with a significant portion of patients failing to improve with current treatments. The purpose of this study is to understand the brain mechanisms that produce fear and anxiety in humans. To accomplish this goal, we will measure the brain activity along with the heart rate and skin perspiration of patients while they are completing tasks on a computer. Some of the tasks will also use a virtual reality headset and transport the patient in a video game-like environment. These tasks will expose the participants to various levels of fear-provoking images. Participants with responsive neurostimulation (RNS) implants will be enrolled under Pro00117931 at Duke, but their results for fear and anxiety tasks will be reported under NCT05120635.

Interventions

  • Device Deep Brain Stimulation
    Deep brain stimulation will be used
  • Behavioral Virtual and augmented reality tasks
    Virtual and augmented reality tasks will be used.

Primary outcome measures

  • Physiological change - eye-blinks [Time frame: during the intervention/behavioral tasks with and without stimulation]
  • Physiological change - heart rate variability [Time frame: during the intervention/behavioral tasks with and without stimulation]
  • Physiological change - skin conductance [Time frame: during the intervention/behavioral tasks with and without stimulation]
  • Neurophysiological activity [Time frame: during the intervention/behavioral tasks with and without stimulation]

Eligibility criteria

Inclusion criteria

  • 18 years of age or older
  • Has undergone acute depth or chronic responsive neurostimulation (RNS) electrode placement
  • Willing to provide informed consent and participate in the study
  • Ability to read and write English fluently

Exclusion criteria

  • Unwilling to provide informed consent
  • Has not undergone acute depth or chronic responsive neurostimulation (RNS) electrode placement
  • Pregnant women
  • Participants with active psychosis
  • Participants with suicidal ideation
  • Participants with substance abuse issues

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Single group
Masking
Double blind
Primary purpose
Basic science

Study locations

United States · 2 centers
  • University of California Los Angeles — Los Angeles
  • Duke University Health System — Durham

Identifiers

NCT: NCT05120635 · PRO00118015 · R01MH124761 · Pro00117931

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗